MedWatch

Carb-X investment gives Snipr Biome validation before going to clinic

Snipr Biome has received a capital injection from antibiotics alliance Carb-X totaling up to USD 10.2m. CEO Christian Grøndahl thinks this will aid the company in its upcoming financing round.

Snipr Biome CEO Christian Grøndahl | Photo: EY / PR

Snipr Biome is delighted with the money recently placed in its account by global antibiotics alliance Carb-X, although the company was already keeping its head above water.

Company CEO Christian Grøndahl is particularly pleased with the fact that this grant comes from Carb-X since in a sense, it represents more than another source of financing.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs